{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:59:37Z","timestamp":1790791177121,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.modpat.2023.100371","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T02:16:12Z","timestamp":1698459372000},"page":"100371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma\u2013Specific Prognostic Relevance"],"prefix":"10.1016","volume":"37","author":[{"given":"Juliana Mota","family":"Siqueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Oliveira","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Guimaraes de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario L.","family":"Marques-Piubelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Purushothaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiaw-Yih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Spiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab Y.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"McGrail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel K.","family":"El-Naggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-215X","authenticated-orcid":false,"given":"Renata","family":"Ferrarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2023.100371_bib1","series-title":"World Health Organization classification of tumours","first-page":"p.347","author":"El-Naggar","year":"2017"},{"issue":"1","key":"10.1016\/j.modpat.2023.100371_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12105-022-01420-1","article-title":"Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands","volume":"16","author":"Skalova","year":"2022","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.modpat.2023.100371_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102959","article-title":"Major and minor salivary gland tumours","volume":"152","author":"Gatta","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100371_bib4","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1177\/014556131709600319","article-title":"The rising incidence of major salivary gland cancer in the United States","volume":"96","author":"Del Signore","year":"2017","journal-title":"Ear Nose Throat J"},{"issue":"17","key":"10.1016\/j.modpat.2023.100371_bib5","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.21.00449","article-title":"Management of salivary gland malignancy: ASCO guideline","volume":"39","author":"Geiger","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2023.100371_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and neck cancers, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.modpat.2023.100371_bib7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3109\/00016489.2016.1170876","article-title":"Combination chemotherapy of carboplatin and paclitaxel for advanced\/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses","volume":"136","author":"Nakano","year":"2016","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100371_bib8","first-page":"843","article-title":"Carboplatin and docetaxel in patients with salivary gland carcinoma: a retrospective study","volume":"33","author":"Okada","year":"2019","journal-title":"In\u00a0Vivo"},{"issue":"2","key":"10.1016\/j.modpat.2023.100371_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.24745","article-title":"A\u00a0phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group","volume":"116","author":"Laurie","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2023.100371_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.annonc.a010684","article-title":"Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients","volume":"7","author":"Licitra","year":"1996","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100371_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cncr.33968","article-title":"Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified","volume":"128","author":"Sousa","year":"2022","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2023.100371_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review","volume":"12","author":"Laurie","year":"2011","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2023.100371_bib13","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdw287","article-title":"A\u00a0phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma","volume":"27","author":"Ho","year":"2016","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.modpat.2023.100371_bib14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.18.01859","article-title":"Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2023.100371_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211013626","article-title":"Apatinib in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a single-arm, phase II prospective study","volume":"13","author":"Zhu","year":"2021","journal-title":"Ther Adv Med Oncol"},{"issue":"15","key":"10.1016\/j.modpat.2023.100371_bib16","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1158\/1078-0432.CCR-16-2942","article-title":"A\u00a0phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma","volume":"23","author":"Dillon","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2023.100371_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejca.2016.09.022","article-title":"A\u00a0phase II study of sorafenib in recurrent and\/or metastatic salivary gland carcinomas: Translational analyses and clinical impact","volume":"69","author":"Locati","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2023.100371_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hed.23577","article-title":"Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck","volume":"37","author":"Thomson","year":"2015","journal-title":"Head Neck"},{"issue":"15_suppl","key":"10.1016\/j.modpat.2023.100371_bib19","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1200\/JCO.2016.34.15_suppl.6086","article-title":"PACSA: phase II study of pazopanib in patients with progressive recurrent or metastatic (R\/M) salivary gland carcinoma (SGC)","volume":"34","author":"Guigay","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100371_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12105-013-0426-3","article-title":"Adenoid cystic carcinoma: clinical and molecular features","volume":"7","author":"Moskaluk","year":"2013","journal-title":"Head Neck Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2023.100371_bib21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cncr.29959","article-title":"In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type","volume":"122","author":"Bell","year":"2016","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2023.100371_bib22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41419-022-05133-9","article-title":"AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling","volume":"13","author":"Ferrarotto","year":"2022","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.modpat.2023.100371_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.2016.67.5264","article-title":"Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to notch1 inhibitors","volume":"35","author":"Ferrarotto","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"36","key":"10.1016\/j.modpat.2023.100371_bib24","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1200\/JCO.22.00229","article-title":"Phase II study of enzalutamide for patients with androgen receptor-positive salivary gland cancers (Alliance A091404)","volume":"40","author":"Ho","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.modpat.2023.100371_bib25","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1158\/1078-0432.CCR-14-1746","article-title":"Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications","volume":"20","author":"Mitani","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.modpat.2023.100371_bib26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2023.100371_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","article-title":"B7-H4, a molecule of the B7 family, negatively regulates T cell immunity","volume":"18","author":"Sica","year":"2003","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.modpat.2023.100371_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri1349","article-title":"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity","volume":"4","author":"Chen","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100371_bib29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","article-title":"Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets","volume":"27","author":"Ferrarotto","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.modpat.2023.100371_bib30","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1002\/cncr.31600","article-title":"Frequent PTEN loss and differential HER2\/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy","volume":"124","author":"Saintigny","year":"2018","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2023.100371_bib31","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-09-0238","article-title":"Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance","volume":"16","author":"Williams","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2023.100371_bib32","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100371_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12530","article-title":"Potential targeting of B7-H4 for the treatment of cancer","volume":"276","author":"Podojil","year":"2017","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.modpat.2023.100371_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.2009.00768.x","article-title":"Fine tuning the immune response through B7-H3 and B7-H4","volume":"229","author":"Yi","year":"2009","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.modpat.2023.100371_bib35","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.171.9.4650","article-title":"Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family","volume":"171","author":"Choi","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.modpat.2023.100371_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.06.011","article-title":"B7-H4 expression in ovarian serous carcinoma: a study of 306 cases","volume":"57","author":"Liang","year":"2016","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2023.100371_bib37","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/mp5007745","article-title":"An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer","volume":"12","author":"Leong","year":"2015","journal-title":"Mol Pharm"},{"issue":"19","key":"10.1016\/j.modpat.2023.100371_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910719","article-title":"The positive and negative immunoregulatory role of B7 family: promising novel targets in gastric cancer treatment","volume":"22","author":"Bolandi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.modpat.2023.100371_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","article-title":"B7-H3 and B7-H4 expression in non-small-cell lung cancer","volume":"53","author":"Sun","year":"2006","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2023.100371_bib40","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/1756-185X.13041","article-title":"B7-H4 deficiency in salivary gland of patients with primary Sj\u00f6gren's syndrome impairs the regulatory effect on T cells","volume":"20","author":"Li","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.modpat.2023.100371_bib41","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fimmu.2017.01765","article-title":"Immunosuppressive effect of B7-H4 pathway in a murine systemic lupus erythematosus model","volume":"8","author":"Xiao","year":"2017","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.modpat.2023.100371_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000166","article-title":"Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data","volume":"6","author":"Azuma","year":"2009","journal-title":"PLoS Med"},{"issue":"16","key":"10.1016\/j.modpat.2023.100371_bib43","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/1078-0432.CCR-23-0514","article-title":"Spatial immunoprofiling of adenoid cystic carcinoma reveals B7-H4 is a therapeutic target for aggressive tumors","volume":"29","author":"de Sousa","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.modpat.2023.100371_bib44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/cancers13051015","article-title":"The exciting new field of HER2-low breast cancer treatment","volume":"13","author":"Eiger","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.modpat.2023.100371_bib45","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1158\/1078-0432.CCR-19-3758","article-title":"The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype","volume":"26","author":"Linxweiler","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2023.100371_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.580141","article-title":"Salivary gland carcinoma: novel targets to overcome treatment resistance in advanced disease","volume":"10","author":"Di Villeneuve","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100371_bib47","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1186\/s12885-022-10159-5","article-title":"B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition","volume":"22","author":"Yan","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.modpat.2023.100371_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2017.05.023","article-title":"B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer","volume":"66","author":"Shen","year":"2017","journal-title":"Hum Pathol"},{"issue":"27","key":"10.1016\/j.modpat.2023.100371_bib49","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1073\/pnas.0600937103","article-title":"B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival","volume":"103","author":"Krambeck","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.modpat.2023.100371_bib50","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/1078-0432.CCR-22-2630","article-title":"Design and preclinical evaluation of a novel B7-H4-directed antibody-drug conjugate, AZD8205, alone and in combination with the PARP1-selective inhibitor AZD5305","volume":"29","author":"Kinneer","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.modpat.2023.100371_bib51","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1200\/JCO.2019.37.15_suppl.6084","article-title":"A\u00a0phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent\/metastatic adenoid cystic carcinoma (R\/M ACC)","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2023.100371_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12935-018-0597-9","article-title":"B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer","volume":"18","author":"Wang","year":"2018","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.modpat.2023.100371_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.archoralbio.2017.07.004","article-title":"Immunohistochemical investigations on the expression of programmed cell death ligand 1, human leukocyte antigens G and E, and granzyme B in intraoral mucoepidermoid carcinoma","volume":"83","author":"Mosconi","year":"2017","journal-title":"Arch Oral Biol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100371_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12105-012-0403-2","article-title":"P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas","volume":"7","author":"Sams","year":"2013","journal-title":"Head Neck Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100371_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1658-3876(09)50035-0","article-title":"Acinic cell carcinoma of the salivary glands: a literature review","volume":"2","author":"Al-Zaher","year":"2009","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"12","key":"10.1016\/j.modpat.2023.100371_bib56","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223002764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223002764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:26:08Z","timestamp":1760232368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223002764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0893395223002764"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100371","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma\u2013Specific Prognostic Relevance","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100371"}}